MEDLAB CLINICAL LIMITED - Announcements

0.00%

$6.60

Currently unlisted.

Healthcare Biotechnology

Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company. The Company... Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company. The Company specializes in the application of NanoCelle drug delivery technology to existing and new pharmaceuticals with the objective of empowering patients with chronic diseases and mental health conditions and enhancing their lives. Its drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The Company's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress. It also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory. It is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas.More

NATURAL MEDICINE LEADERS

The Calmer Co (ASX:CCO) FY25 Revenue Hits $8M, Up 86% on FY24

Announcements

Filter Results

All Price Sensitive Only

MDC	Removal from Official List		28/02/25	534.11KB	Share
MDC	Results of Meeting 2024		14/02/25	94.2KB	Share
MDC	Results of Meeting 2023		14/02/25	94.45KB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	03/02/25	344.45KB	Share
MDC	Long Term Suspended Entities	PRICE SENSITIVE	22/01/25	201.08KB	Share
MDC	Notice of Annual General Meeting/Proxy Form		10/01/25	398.55KB	Share
MDC	Notice of General Meeting/Proxy Form		10/01/25	412.84KB	Share
MDC	Response to Appendices 3X and 3Z Query		13/12/24	792.85KB	Share
MDC	Final Director's Interest Notice		04/12/24	157.81KB	Share
MDC	Initial Director's Interest Notice		04/12/24	194.91KB	Share
MDC	MDC Board Composition Changes		04/12/24	166.12KB	Share
MDC	Annual Report to shareholders	PRICE SENSITIVE	04/11/24	1.38MB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/24	338.85KB	Share
MDC	Long Term Suspended Entities	PRICE SENSITIVE	18/10/24	195.7KB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/24	332.56KB	Share
MDC	Long Term Suspended Entities	PRICE SENSITIVE	10/07/24	202.22KB	Share
MDC	Half Yearly Report and Accounts	PRICE SENSITIVE	15/05/24	1.81MB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	343.84KB	Share
MDC	Addendum to 2023 Annual Report - Shareholder Information		24/04/24	192.63KB	Share
MDC	MDC Annual Report to shareholders	PRICE SENSITIVE	24/04/24	2.1MB	Share
MDC	Auditor Appointment/Resignation		02/04/24	166.01KB	Share
MDC	Final Director's Interest Notice		28/03/24	299.9KB	Share
MDC	Initial Director's Interest Notice		28/03/24	374.07KB	Share
MDC	MDC Board of Directors Composition Update		28/03/24	171.15KB	Share
MDC	MDC ASX Release Change of Share Registry Provider		29/02/24	145.21KB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	340.71KB	Share
MDC	Medlab Settlement of Share Sale Deed	PRICE SENSITIVE	15/01/24	121.56KB	Share
MDC	MDC HY23 Interim Report	PRICE SENSITIVE	09/01/24	510.57KB	Share
MDC	MDC 2023 EGM Voting Results		22/12/23	179.3KB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	08/12/23	1.09MB	Share
MDC	Notice of Extraordinary General Meeting / Proxy Form	PRICE SENSITIVE	22/11/23	3.2MB	Share
MDC	Shareholder Update - Restructuring Transaction	PRICE SENSITIVE	09/11/23	170.22KB	Share
MDC	Medlab Update to Shareholders	PRICE SENSITIVE	12/09/23	133.98KB	Share
MDC	Suspension from Official Quotation - Annual Listing Fees		22/08/23	447.33KB	Share
MDC	Medlab Update to Shareholders		03/08/23	115.82KB	Share
MDC	Medlab Update to Shareholders	PRICE SENSITIVE	07/06/23	101.01KB	Share
MDC	Response to ASX Query		23/03/23	179.75KB	Share
MDC	Medlab Update to Shareholders	PRICE SENSITIVE	21/03/23	372.95KB	Share
MDC	Final Director's Interest Notice		16/03/23	764.45KB	Share
MDC	Initial Director's Interest Notice		16/03/23	372.34KB	Share
MDC	Company Status and Board Composition Updates	PRICE SENSITIVE	16/03/23	191.22KB	Share
MDC	Appointment of External Consultants to Medlab	PRICE SENSITIVE	06/03/23	174.6KB	Share
MDC	Suspension from Official Quotation	PRICE SENSITIVE	27/02/23	86.43KB	Share
MDC	Trading Halt	PRICE SENSITIVE	23/02/23	438.74KB	Share
MDC	Aust ODC Approves NanaDol Export for UK Use	PRICE SENSITIVE	07/02/23	152.61KB	Share
MDC	Appendix 4C Administrative Clarification	PRICE SENSITIVE	01/02/23	385.58KB	Share
MDC	UK Home Office Grants UK Import Certificate for NanaBis	PRICE SENSITIVE	25/01/23	155.87KB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	20/01/23	381.06KB	Share
MDC	Medlab Announces Interim Readout of RWE Medcare Study	PRICE SENSITIVE	12/01/23	208.1KB	Share
MDC	Medlab Files Registration Statement for Proposed US IPO	PRICE SENSITIVE	28/12/22	173.82KB	Share
MDC	NASDAQ Progression - Medlab Clears SEC Comments	PRICE SENSITIVE	08/12/22	151.76KB	Share
MDC	First Tranche IP Royalty Payment from Pharmacare	PRICE SENSITIVE	01/12/22	149.5KB	Share
MDC	Medlab receives UK Import Permission from MHRA for NanaBis	PRICE SENSITIVE	25/11/22	169.13KB	Share
MDC	Jefferies HealthCare Conference NanoCelle Presentation	PRICE SENSITIVE	16/11/22	11.15MB	Share
MDC	NanoCelle Nasal RNA (Nucleid Acid) Program Update	PRICE SENSITIVE	10/11/22	158.76KB	Share
MDC	Medlab Presents NanoCelle at Jefferies Conference London		09/11/22	169.34KB	Share
MDC	Notification of cessation of securities - MDC		01/11/22	22KB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/22	403.82KB	Share
MDC	Grant of waiver of Listing Rule 14.7		21/10/22	198.11KB	Share
MDC	MDC 2022 AGM Voting Results		30/09/22	195.83KB	Share
MDC	Medlab AGM Presentation		30/09/22	15.65MB	Share
MDC	Medlab Progresses Nasdaq Dual Listing		28/09/22	159.36KB	Share
MDC	Medlab Received 2022 R&D Claim	PRICE SENSITIVE	26/09/22	162.59KB	Share
MDC	NanaBis and NanoCBD Clinical Development Update		16/09/22	185.37KB	Share
MDC	Final Director's Interest Notice		06/09/22	209.58KB	Share
MDC	MDC Director Resignation Announcement		31/08/22	157.22KB	Share
MDC	Corporate Governance Statement 2022		30/08/22	212.05KB	Share
MDC	Appendix 4G		30/08/22	273.21KB	Share
MDC	Annual Report to shareholders		30/08/22	10.4MB	Share
MDC	Preliminary Final Report	PRICE SENSITIVE	30/08/22	99.26KB	Share
MDC	MDC Notice of Annual General Meeting/Proxy Form		29/08/22	446.25KB	Share
MDC	Biotech Investors' Conference Presentation		17/08/22	11.55MB	Share
MDC	Depression European Patent Accepted, Proceeding to Grant	PRICE SENSITIVE	10/08/22	201.84KB	Share
MDC	Initial Director's Interest Notice		08/08/22	193.07KB	Share
MDC	Leading Healthcare Executive joins Medlab Board		08/08/22	159.31KB	Share
MDC	Share Consolidation update & despatch of holding statements		05/08/22	125.32KB	Share
MDC	UNSW Medlab Laboratory Collaboration Additional Information	PRICE SENSITIVE	02/08/22	195.48KB	Share
MDC	Medlab enters Laboratory Collaboration with UNSW, Sydney	PRICE SENSITIVE	01/08/22	153.33KB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/22	387.97KB	Share
MDC	Results of MDC July 2022 EGM		28/07/22	180.09KB	Share
MDC	Change of Director's Interest Notice		13/07/22	377.77KB	Share
MDC	Change of Director's Interest Notice		11/07/22	228.43KB	Share
MDC	Consolidation/Split - MDC		30/06/22	28.02KB	Share
MDC	EGM Notice of Meeting to Approve Dual Listing to Nasdaq	PRICE SENSITIVE	29/06/22	1.05MB	Share
MDC	Trading Halt	PRICE SENSITIVE	28/06/22	326.8KB	Share
MDC	Pause in Trading	PRICE SENSITIVE	28/06/22	116.07KB	Share
MDC	NanaBis Independently Confirmed BioAvailability	PRICE SENSITIVE	27/06/22	227.72KB	Share
MDC	Medlab signs exclusive commercial agreement with YesHealth	PRICE SENSITIVE	23/06/22	136.24KB	Share
MDC	Progression of NanoCelle NASAL COVID-19 Vaccine Program	PRICE SENSITIVE	31/05/22	181.7KB	Share
MDC	Biotech Investors Luncheon Presentations		16/05/22	2.88MB	Share
MDC	GTG: Biotech Investors Presentation		16/05/22	2.52MB	Share
MDC	Medlab Signs NRG Biotic Trade Deal with Cultech Ltd	PRICE SENSITIVE	20/04/22	201.69KB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	14/04/22	3.62MB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	13/04/22	3.38MB	Share
MDC	NanoCBD Awaiting UK Govt. Import Approval		12/04/22	194.47KB	Share
MDC	CEO Buys Medlab Shares - Appendix 3Y		04/04/22	227.01KB	Share
MDC	CEO Buys Medlab Shares - Appendix 3Y		01/04/22	227.38KB	Share
MDC	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/22	626.22KB	Share
MDC	UK Ethics favourable opinion for upcoming NanaBis P3 Trial	PRICE SENSITIVE	07/02/22	191.1KB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/01/22	420.9KB	Share

MDC Removal from Official List
28/02/25		534.11KB	Share
MDC Results of Meeting 2024
14/02/25		94.2KB	Share
MDC Results of Meeting 2023
14/02/25		94.45KB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
03/02/25	PRICE SENSITIVE	344.45KB	Share
MDC Long Term Suspended Entities
22/01/25	PRICE SENSITIVE	201.08KB	Share
MDC Notice of Annual General Meeting/Proxy Form
10/01/25		398.55KB	Share
MDC Notice of General Meeting/Proxy Form
10/01/25		412.84KB	Share
MDC Response to Appendices 3X and 3Z Query
13/12/24		792.85KB	Share
MDC Final Director's Interest Notice
04/12/24		157.81KB	Share
MDC Initial Director's Interest Notice
04/12/24		194.91KB	Share
MDC MDC Board Composition Changes
04/12/24		166.12KB	Share
MDC Annual Report to shareholders
04/11/24	PRICE SENSITIVE	1.38MB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
31/10/24	PRICE SENSITIVE	338.85KB	Share
MDC Long Term Suspended Entities
18/10/24	PRICE SENSITIVE	195.7KB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24	PRICE SENSITIVE	332.56KB	Share
MDC Long Term Suspended Entities
10/07/24	PRICE SENSITIVE	202.22KB	Share
MDC Half Yearly Report and Accounts
15/05/24	PRICE SENSITIVE	1.81MB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	343.84KB	Share
MDC Addendum to 2023 Annual Report - Shareholder Information
24/04/24		192.63KB	Share
MDC MDC Annual Report to shareholders
24/04/24	PRICE SENSITIVE	2.1MB	Share
MDC Auditor Appointment/Resignation
02/04/24		166.01KB	Share
MDC Final Director's Interest Notice
28/03/24		299.9KB	Share
MDC Initial Director's Interest Notice
28/03/24		374.07KB	Share
MDC MDC Board of Directors Composition Update
28/03/24		171.15KB	Share
MDC MDC ASX Release Change of Share Registry Provider
29/02/24		145.21KB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	340.71KB	Share
MDC Medlab Settlement of Share Sale Deed
15/01/24	PRICE SENSITIVE	121.56KB	Share
MDC MDC HY23 Interim Report
09/01/24	PRICE SENSITIVE	510.57KB	Share
MDC MDC 2023 EGM Voting Results
22/12/23		179.3KB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
08/12/23	PRICE SENSITIVE	1.09MB	Share
MDC Notice of Extraordinary General Meeting / Proxy Form
22/11/23	PRICE SENSITIVE	3.2MB	Share
MDC Shareholder Update - Restructuring Transaction
09/11/23	PRICE SENSITIVE	170.22KB	Share
MDC Medlab Update to Shareholders
12/09/23	PRICE SENSITIVE	133.98KB	Share
MDC Suspension from Official Quotation - Annual Listing Fees
22/08/23		447.33KB	Share
MDC Medlab Update to Shareholders
03/08/23		115.82KB	Share
MDC Medlab Update to Shareholders
07/06/23	PRICE SENSITIVE	101.01KB	Share
MDC Response to ASX Query
23/03/23		179.75KB	Share
MDC Medlab Update to Shareholders
21/03/23	PRICE SENSITIVE	372.95KB	Share
MDC Final Director's Interest Notice
16/03/23		764.45KB	Share
MDC Initial Director's Interest Notice
16/03/23		372.34KB	Share
MDC Company Status and Board Composition Updates
16/03/23	PRICE SENSITIVE	191.22KB	Share
MDC Appointment of External Consultants to Medlab
06/03/23	PRICE SENSITIVE	174.6KB	Share
MDC Suspension from Official Quotation
27/02/23	PRICE SENSITIVE	86.43KB	Share
MDC Trading Halt
23/02/23	PRICE SENSITIVE	438.74KB	Share
MDC Aust ODC Approves NanaDol Export for UK Use
07/02/23	PRICE SENSITIVE	152.61KB	Share
MDC Appendix 4C Administrative Clarification
01/02/23	PRICE SENSITIVE	385.58KB	Share
MDC UK Home Office Grants UK Import Certificate for NanaBis
25/01/23	PRICE SENSITIVE	155.87KB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
20/01/23	PRICE SENSITIVE	381.06KB	Share
MDC Medlab Announces Interim Readout of RWE Medcare Study
12/01/23	PRICE SENSITIVE	208.1KB	Share
MDC Medlab Files Registration Statement for Proposed US IPO
28/12/22	PRICE SENSITIVE	173.82KB	Share
MDC NASDAQ Progression - Medlab Clears SEC Comments
08/12/22	PRICE SENSITIVE	151.76KB	Share
MDC First Tranche IP Royalty Payment from Pharmacare
01/12/22	PRICE SENSITIVE	149.5KB	Share
MDC Medlab receives UK Import Permission from MHRA for NanaBis
25/11/22	PRICE SENSITIVE	169.13KB	Share
MDC Jefferies HealthCare Conference NanoCelle Presentation
16/11/22	PRICE SENSITIVE	11.15MB	Share
MDC NanoCelle Nasal RNA (Nucleid Acid) Program Update
10/11/22	PRICE SENSITIVE	158.76KB	Share
MDC Medlab Presents NanoCelle at Jefferies Conference London
09/11/22		169.34KB	Share
MDC Notification of cessation of securities - MDC
01/11/22		22KB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
28/10/22	PRICE SENSITIVE	403.82KB	Share
MDC Grant of waiver of Listing Rule 14.7
21/10/22		198.11KB	Share
MDC MDC 2022 AGM Voting Results
30/09/22		195.83KB	Share
MDC Medlab AGM Presentation
30/09/22		15.65MB	Share
MDC Medlab Progresses Nasdaq Dual Listing
28/09/22		159.36KB	Share
MDC Medlab Received 2022 R&D Claim
26/09/22	PRICE SENSITIVE	162.59KB	Share
MDC NanaBis and NanoCBD Clinical Development Update
16/09/22		185.37KB	Share
MDC Final Director's Interest Notice
06/09/22		209.58KB	Share
MDC MDC Director Resignation Announcement
31/08/22		157.22KB	Share
MDC Corporate Governance Statement 2022
30/08/22		212.05KB	Share
MDC Appendix 4G
30/08/22		273.21KB	Share
MDC Annual Report to shareholders
30/08/22		10.4MB	Share
MDC Preliminary Final Report
30/08/22	PRICE SENSITIVE	99.26KB	Share
MDC MDC Notice of Annual General Meeting/Proxy Form
29/08/22		446.25KB	Share
MDC Biotech Investors' Conference Presentation
17/08/22		11.55MB	Share
MDC Depression European Patent Accepted, Proceeding to Grant
10/08/22	PRICE SENSITIVE	201.84KB	Share
MDC Initial Director's Interest Notice
08/08/22		193.07KB	Share
MDC Leading Healthcare Executive joins Medlab Board
08/08/22		159.31KB	Share
MDC Share Consolidation update & despatch of holding statements
05/08/22		125.32KB	Share
MDC UNSW Medlab Laboratory Collaboration Additional Information
02/08/22	PRICE SENSITIVE	195.48KB	Share
MDC Medlab enters Laboratory Collaboration with UNSW, Sydney
01/08/22	PRICE SENSITIVE	153.33KB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
29/07/22	PRICE SENSITIVE	387.97KB	Share
MDC Results of MDC July 2022 EGM
28/07/22		180.09KB	Share
MDC Change of Director's Interest Notice
13/07/22		377.77KB	Share
MDC Change of Director's Interest Notice
11/07/22		228.43KB	Share
MDC Consolidation/Split - MDC
30/06/22		28.02KB	Share
MDC EGM Notice of Meeting to Approve Dual Listing to Nasdaq
29/06/22	PRICE SENSITIVE	1.05MB	Share
MDC Trading Halt
28/06/22	PRICE SENSITIVE	326.8KB	Share
MDC Pause in Trading
28/06/22	PRICE SENSITIVE	116.07KB	Share
MDC NanaBis Independently Confirmed BioAvailability
27/06/22	PRICE SENSITIVE	227.72KB	Share
MDC Medlab signs exclusive commercial agreement with YesHealth
23/06/22	PRICE SENSITIVE	136.24KB	Share
MDC Progression of NanoCelle NASAL COVID-19 Vaccine Program
31/05/22	PRICE SENSITIVE	181.7KB	Share
MDC Biotech Investors Luncheon Presentations
16/05/22		2.88MB	Share
MDC GTG: Biotech Investors Presentation
16/05/22		2.52MB	Share
MDC Medlab Signs NRG Biotic Trade Deal with Cultech Ltd
20/04/22	PRICE SENSITIVE	201.69KB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
14/04/22	PRICE SENSITIVE	3.62MB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
13/04/22	PRICE SENSITIVE	3.38MB	Share
MDC NanoCBD Awaiting UK Govt. Import Approval
12/04/22		194.47KB	Share
MDC CEO Buys Medlab Shares - Appendix 3Y
04/04/22		227.01KB	Share
MDC CEO Buys Medlab Shares - Appendix 3Y
01/04/22		227.38KB	Share
MDC Half Yearly Report and Accounts
24/02/22	PRICE SENSITIVE	626.22KB	Share
MDC UK Ethics favourable opinion for upcoming NanaBis P3 Trial
07/02/22	PRICE SENSITIVE	191.1KB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
27/01/22	PRICE SENSITIVE	420.9KB	Share

REFRESH

1 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

MEDLAB CLINICAL LIMITED - Announcements

Announcements

Top Stories